Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1α,25-dihydroxyvitamin D3 and 20-epi-2-methyl-1α,25-dihydroxyvitamin D3
暂无分享,去创建一个
H. DeLuca | S. Maki | K. Nakagawa | T. Okano | M. Kurobe | K. Konno | H. Takayama | M. Chokki | S. Ishizuka | T. Fujishima | Zhaopeng Liu | D. Miura | C. Smith
[1] K. Nakagawa,et al. Structure-specific control of differentiation and apoptosis of human promyelocytic leukemia (HL-60) cells by A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and its 20-epimer. , 2000, Biochemical pharmacology.
[2] K. Ozono,et al. Novel ring A stereoisomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 2-methyl-20-epi-1alpha,25-dihydroxyvitamin D(3): transactivation of target genes and modulation of differentiation in human promyelocytic leukemia (HL-60) cells. , 2000, Biochemical pharmacology.
[3] H. DeLuca,et al. New 1alpha,25-dihydroxy-19-norvitamin D3 compounds of high biological activity: synthesis and biological evaluation of 2-hydroxymethyl, 2-methyl, and 2-methylene analogues. , 1998, Journal of medicinal chemistry.
[4] K. Konno,et al. Synthesis and biological activity of 2-methyl-20-epi analogues of 1α,25-dihydroxyvitamin D3 , 1998 .
[5] S. Maki,et al. A novel and practical route to A-ring enyne synthon for 1α,25-dihydroxyvitamin D3 analogs: Synthesis of A-ring diastereomers of 1α,25-dihydroxyvitamin D3 and 2-methyl-1,25-dihydroxyvitamin D3 , 1998 .
[6] D. Feldman,et al. Chemistry and design: structural biology of vitamin D action , 1997 .
[7] H. DeLuca,et al. The Vitamin D Endocrine System and Its Therapeutic Potential , 1996 .
[8] A. Kutner,et al. Crystal and molecular structure of 1,25‐dihydroxycholecalciferol , 1996 .
[9] R. Bouillon,et al. Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.
[10] S. Rychnovsky,et al. Analysis of two carbon-13 NMR correlations for determining the stereochemistry of 1,3-diol acetonides , 1993 .
[11] A. Lera,et al. Studies of vitamin D (calciferol) and its analogs. 45. Studies on the A-ring diastereomers of 1.alpha.,25-dihydroxyvitamin D3 , 1993 .
[12] B. Trost,et al. New strategies for the synthesis of vitamin D metabolites via palladium-catalyzed reactions , 1992 .
[13] T. D. Nelson,et al. New vitamin D3 derivatives with unexpected antiproliferative activity: 1-(hydroxymethyl)-25-hydroxyvitamin D3 homologs. , 1992, Journal of medicinal chemistry.
[14] T. Kusumi,et al. High-field FT NMR application of Mosher's method. The absolute configurations of marine terpenoids , 1991 .
[15] A. Norman,et al. Vitamin D: concerning the relationship between molecular topology and biological function. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[16] F. Anet. The Use of Remote Deuteration for The Determination of Coupling Constants and Conformational Equilibria in Cyclohexane Derivatives , 1962 .
[17] H. DeLuca,et al. 1α,25-dihydroxy-19-nor-vitamin D3, a novel vitamin D-related compound with potential therapeutic activity , 1990 .